"Transcription Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.
| Descriptor ID |
D014157
|
| MeSH Number(s) |
D12.776.930
|
| Concept/Terms |
Transcription Factors- Transcription Factors
- Factors, Transcription
- Transcription Factor
- Factor, Transcription
|
Below are MeSH descriptors whose meaning is more general than "Transcription Factors".
Below are MeSH descriptors whose meaning is more specific than "Transcription Factors".
This graph shows the total number of publications written about "Transcription Factors" by people in this website by year, and whether "Transcription Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 14 | 10 | 24 |
| 1997 | 29 | 14 | 43 |
| 1998 | 25 | 9 | 34 |
| 1999 | 35 | 11 | 46 |
| 2000 | 38 | 14 | 52 |
| 2001 | 45 | 12 | 57 |
| 2002 | 44 | 27 | 71 |
| 2003 | 48 | 32 | 80 |
| 2004 | 58 | 23 | 81 |
| 2005 | 46 | 36 | 82 |
| 2006 | 30 | 21 | 51 |
| 2007 | 31 | 25 | 56 |
| 2008 | 29 | 17 | 46 |
| 2009 | 28 | 21 | 49 |
| 2010 | 31 | 18 | 49 |
| 2011 | 24 | 19 | 43 |
| 2012 | 27 | 26 | 53 |
| 2013 | 30 | 32 | 62 |
| 2014 | 27 | 39 | 66 |
| 2015 | 36 | 25 | 61 |
| 2016 | 30 | 28 | 58 |
| 2017 | 31 | 32 | 63 |
| 2018 | 29 | 17 | 46 |
| 2019 | 20 | 30 | 50 |
| 2020 | 31 | 32 | 63 |
| 2021 | 26 | 22 | 48 |
| 2022 | 8 | 30 | 38 |
| 2023 | 18 | 36 | 54 |
| 2024 | 20 | 20 | 40 |
| 2025 | 21 | 15 | 36 |
| 2026 | 7 | 5 | 12 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transcription Factors" by people in Profiles.
-
Overcoming menin inhibitor resistance in AML cells with combinations including BET proteins and a dual BRG1/BRM inhibitor. Blood. 2026 Jun 04; 147(23):2809-2820.
-
Targeting tumor-associated macrophage-induced IGF1/PI3K/Zic1 axis triggers SHH medulloblastoma regression and chemosensitization. Neuro Oncol. 2026 Jun 01; 28(6):1556-1570.
-
Role of the ETV5/p38 Signaling Axis in Aggressive Thyroid Cancer Cells. Mol Cancer Ther. 2026 May 04; 25(5):844-859.
-
Regulation of STK38 by autophagy governs YAP1 activity during paligenosis. Proc Natl Acad Sci U S A. 2026 Apr 07; 123(14):e2517488123.
-
Family single-cell atlases reveal pig pregnancy and fetal growth restriction critical cell types. Science. 2026 Mar 26; 391(6792):eadu7265.
-
Dominant clones leverage developmental epigenomic states to drive ependymoma. Nature. 2026 04; 652(8111):1027-1037.
-
Expanding the phenotypic spectrum of MECOM-associated syndrome: rare variants are associated with syndromic pulmonary arterial hypertension. J Med Genet. 2026 Mar 20; 63(4):225-234.
-
Frequent synaptophysin expression in SMARCA4-deficient undifferentiated carcinoma of the oesophagus: a diagnostic pitfall with therapeutic implications. J Clin Pathol. 2026 Mar 19; 79(4):229-237.
-
Paediatric Therapeutic Development Workshop on rhabdoid tumours. Br J Cancer. 2026 Jun; 134(11):1510-1528.
-
PTPN1 Regulation via YBX1-PTBP1 Interaction Promotes Fibroblast Activation and Fibrotic Remodeling in the Lung. Int J Biol Sci. 2026; 22(5):2233-2246.